Edgewise Therapeutics, Inc.
EWTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001710072
In the last 90 days, Edgewise Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 226 institutions reported holding it in 13F filings for Q2 2026, worth $4.82B in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Edgewise Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 72 | 1 | 78 | +7 |
| Shares | 54.0M | 6.30K | 51.0M | −2.99M (−5.5%) |
| Value | $523.5M | $61.0K | $405.7M | −$117.8M (−22.5%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Edgewise Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Oconnor LLC | 125,000 | $995.0K | 0.01% |
| Resolute Capital Asset Partners LLC | 89,190 | $710.0K | 0.51% |
| ExodusPoint Capital Management, LP | 60,028 | $478.0K | 0.01% |
| Ergoteles LLC | 34,600 | $275.0K | 0.01% |
| Renaissance Technologies LLC | 32,600 | $259.0K | 0.00% |
| State Board of Administration of Florida Retirement System | 21,950 | $175.0K | 0.00% |
| Acadian Asset Management LLC | 20,979 | $167.0K | 0.00% |
| Gsa Capital Partners LLP | 17,312 | $138.0K | 0.02% |
| Mirae Asset Global Investments Co., Ltd. | 12,081 | $96.0K | 0.00% |
| Jane Street Group, LLC | 11,505 | $92.0K | 0.00% |
| SG Americas Securities, LLC | 11,334 | $90.0K | 0.00% |
| Nisa Investment Advisors, LLC | 2,900 | $23.0K | 0.00% |
| The PNC Financial Services Group, Inc. | 330 | $2.00K | 0.00% |
| Captrust Financial Advisors | 263 | $2.00K | 0.00% |
| Massmutual Trust Co FSB | 81 | $1.00K | 0.00% |
| Ellevest, Inc. | 108 | $1.00K | 0.00% |
| Credit Suisse AG | 36 | $0 | 0.00% |
Sold out (10)
Institutions that held Edgewise Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Ra Capital Management, L.P. | 2,613,623 | $25.4M |
| Ensign Peak Advisors, Inc | 662,526 | $6.43M |
| Norges Bank | 301,691 | $2.93M |
| State of Wisconsin Investment Board | 51,800 | $502.0K |
| UBS Group AG | 22,047 | $214.0K |
| Atom Investors LP | 15,781 | $153.0K |
| Dynamic Technology Lab Private Ltd | 12,923 | $125.0K |
| ProShare Advisors LLC | 12,378 | $120.0K |
| Private Capital Group, LLC | 151 | $2.00K |
| State of Wyoming | 33 | $0 |
Not filed for Q2 2022 yet (1)
Institutions that held Edgewise Therapeutics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Amalgamated Financial Corp. | 6,299 | $61.0K |